All studies
AuthorisedTherapeutic use (Phase IV)Interventional

Proof-of-Concept Evaluation of Immunological Assays Using Human Blood and Urine Samples after Vaccination with StroVac

Urinary tract infections (UTIs), like cystitis, are common and can be painful and frustrating to deal with, especially if they keep coming back. This clinical study is testing a vaccine called StroVac, which contains inactive (killed) bacteria that commonly cause bladder infections. The main goal of the study is to see how well the body's immune system responds after receiving the vaccine. Doctors will check whether the vaccine increases protective proteins, known as antibodies, in both the blood and the urine. These antibodies help the body recognize and fight off harmful bacteria before they cause an infection. The trial is open to adults aged 18 and older. Researchers will also monitor participants closely to record any side effects and ensure the vaccine is well tolerated throughout the study period.

At a glance

Status
Authorised
Phase
Therapeutic use (Phase IV)
Sponsor
Strathmann GmbH & Co. KG
Enrolment target
20
Start
05 Oct 2026

What is this study about?

Urinary tract infections (UTIs) happen when bacteria get into the bladder or kidneys, causing symptoms like a burning feeling when peeing and needing to go more often. While antibiotics are usually used to treat these infections, repeated infections can be hard to manage. Finding ways to prevent UTIs from happening in the first place could make a big difference to people's daily lives.

StroVac is a vaccine made from several types of bacteria that often cause bladder infections. These bacteria have been inactivated, meaning they are killed and cannot cause an active infection. The goal of the vaccine is to 'train' the body's natural defense system to spot these germs quickly and clear them away.

In this study, researchers want to measure how the immune system responds to the vaccine. Specifically, they are looking at changes in antibodies (protective proteins) in both blood and urine samples before and after people receive the jab. By seeing how antibody levels rise, scientists hope to better understand how StroVac helps the body defend against future infections.

Key takeaways

  • Tests the StroVac vaccine, designed to help prevent urinary tract infections.
  • Measures how natural germ-fighting antibodies rise in your blood and urine.
  • Open to men and women aged 18 and over.
  • Involves clinic visits, vaccine injections, and giving blood and urine samples.
  • Participation is entirely voluntary, and your health will be closely monitored.

Who may be eligible?

This trial is open to adults of any gender who are 18 years old or older. It is aimed at people who want to help researchers learn more about how the immune system responds to bladder infection vaccines.

Because this is a vaccine study, certain health conditions or medications might affect whether you can take part. For example, people with certain allergies or conditions that weaken the immune system may need extra medical checks before joining.

The study team will review your full medical history with you to make sure the trial is safe and suitable for your individual circumstances.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I am able and willing to attend all scheduled clinic appointments.
  3. I am happy to provide blood and urine samples for testing.
  4. I do not have known severe allergies to vaccine ingredients.
  5. I can speak with the study team about my current medications and general health.
Answer every question to see your result.

What does participation involve?

If you decide to take part, you will have several clinic visits over the course of the study. At your first visit, the study team will explain the trial in detail, answer your questions, and collect initial blood and urine samples before you receive the vaccine.

You will receive the StroVac vaccine as an injection. Over the following weeks, you will return for scheduled check-ups (up to Visit 4). During these visits, the team will collect more blood and urine samples to see if your antibody levels have increased. They will also ask about how you are feeling and check for any symptoms or side effects. The study team will provide you with a clear timeline of the total duration and visit dates before you start.

Potential risks and benefits

Taking part in this study may help protect you against future urinary tract infections, although this cannot be guaranteed. Your participation will also provide valuable information that could help improve UTI treatments for others in the future. As with any vaccine, there are potential side effects, such as soreness or redness at the injection site, mild fever, or temporary tiredness. The clinical team will monitor you closely at every step. Joining the study is completely voluntary, and you have the right to withdraw at any time without it affecting your regular medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Germany

Common questions

Can the vaccine give me a urinary tract infection?

No. The bacteria in the StroVac vaccine are inactivated (killed), so they cannot cause an infection.

How is the vaccine given?

The vaccine is given as an injection, usually into a muscle, such as in your upper arm.

Do I have to pay to take part in this study?

No, the study medication and all trial-related tests are provided free of charge.

Can I leave the study if I change my mind?

Yes, you can leave the trial at any point, for any reason, without giving an explanation.

Will taking part replace my usual NHS care?

No. You can still see your regular GP, and the study team will keep your doctor informed if you wish.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.